[1] Green R C, Goldstein F C, Auchus A P, et al. Treatment trial of oxiracetam in alzheimer's disease[J]. Arch Neurol-Chicago, 1992, 49(11): 1 135-1 136.
[2] Villardita C, Grioli S, Lomeo C, et al. Clinical studies with oxiracetam in patients with dementia of alzheimer type and multi-lnfarct dementia of mild to moderate degree[J]. Neuropsychobiology, 1992, 25(1): 24-28.
[3] Pinza M, Farina C, Cerri A, et al. Synthesis and pharmacological activity of a series of dihydro-1h-pyrrolo[1, 2-a] imidazole-2, 5 (3h, 6h)-diones, a novel class of potent cognition enhancers[J]. J Med Chem, 1993, 36(26): 4 214-4 220.
[4] Trovarelli G, Gaiti A, Demedio G, et al. Biochemical studies on the nootropic drug oxiracetam in brain[J]. Clin Neuropharmacol, 1984, 7(suppl 1): S418.
[5] Barfield M, Chakrabarti B. Long-range proton spin-spin coupling[J]. Chem Rev, 1969, 69(6): 757-778.
[6] Kim W, Lee H J, Choi Y S, et al. The nature of rotational barriers of the c-n bond in thioamides and the origin of the nonplanarity for thiourea[J]. J Chem Soc, Faraday Trans, 1998, 94(18): 2 663-2 668.
[7] Stewart W E, Siddall Iii T H. Nuclear magnetic resonance studies of amides[J]. Chem Rev, 1970, 70(5): 517-551.
[8] Cellman S H, Dado G P, Liang C B, et al. Conformation-directing effects of a single intramolecular amide-amide hydrogen bond: variabletemperature nmr and ir studies on a homologous diamide series[J]. Biophys J, 1980, 32: 17.
[9] Shanan-Atidi H, Bar-Eli K H. Convenient method for obtaining free energies of activation by the coalescence temperature of an unequal doublet[J]. J Phys Chem, 1970, 74(4): 961-963.
[10] Qiao Rui-rui(乔瑞瑞), Sun Jing(孙静), Yang Chun-hui(杨春晖), et al. Isomerization of the amide bond in piperidin amides studied by variable-temperature NMR spectroscopy (吡啶酰胺类化合物中酰胺键异构化的变温核磁共振研究) [J]. Chinese J Magn Reson(波谱学杂志), 2008, 25(3): 307-314. |